Profusa, Inc. in brief
Profusa, Inc. is a listed company, based in New York, New York, USA. Its market value was $0 M on 29 October 2026, which makes it the 28,295th largest listed company in the world and the 4,525th largest in the USA on this site. Its shares trade under the symbol PFSA (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
About Profusa, Inc.
Profusa is a digital health technology company based in Berkeley, California, that has invested over the last twelve years more than $100 million from sophisticated venture investors as well as the most sophisticated research institutions in the U.S. (including approximately $30 million from Defense Advance Research Projects Agency, or DARPA, and the National Institutes of Health, or NIH) to develop a unique biosensor platform that is easily injected subcutaneously to provide, for the first time, real-time, individual biochemistry, that is cost effective while functioning for more than six times longer than known best-in-class solutions on the market today. Profusa’s Lumee™ technology does not consist of a single product, but is rather a platform that can potentially launch products for multiple applications.
From the company's annual report filed with the US SEC: read the report
Profusa, Inc. timeline
- 2021
- •· approximateFirst filing with the US SECThe company's first electronic filing in SEC EDGAR.
- 🔔Initial public offering as NorthView Acquisition CorpFinal prospectus filed with the SEC on 22 December 2021; shares registered for exchange trading on 16 December 2021. The blank-check company later merged with the business that carries the name today.
- 2025
- ✎Renamed Profusa, Inc.Formerly NorthView Acquisition Corp.
Events of Profusa, Inc. from SEC EDGAR. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #4,453 (Oct 2026) · #4,528 (Oct 2026)
Key ratios
- P/E ratio
- n/m (loss)
- Price / sales
- —
- Price / book
- —
- Free cash flow yield
- -3459.6%
- Net margin
- —
- Operating margin
- —
- Return on equity
- —
- Liabilities / assets
- 805.0%
- R&D / revenue
- 1610.0%
Financial history
| Fiscal year ending | Revenue | Growth | Operating income | Net income | Net margin |
|---|---|---|---|---|---|
| Dec 2025 | — | — | $-28M | $-36M | — |
| Dec 2024 | $0M | — | $-5M | $-9M | -9230.0% |
| Dec 2023 | — | — | $-2M | $1M | — |
| Dec 2022 | — | — | $-1M | $7M | — |
Cash flow, debt and per share
| Fiscal year ending | Operating cash flow | Capital spending | Free cash flow | EPS (diluted) | Dividend / share |
|---|---|---|---|---|---|
| Dec 2025 | $-16M | $0M | $-16M | $-107.01 | — |
| Dec 2024 | $-2M | — | — | $-357.14 | — |
| Dec 2023 | $-2M | — | — | $0.12 | — |
| Dec 2022 | $-1M | — | — | $0.30 | — |
Quarterly results
Latest quarter to Sep 2026: revenue —, net income $-5M. Lighter bars: fourth quarters worked out from the annual report. Trailing 12 months to Jun 2026.
SEC filings
- Nov 6, 20268-KCurrent reportMaterial agreement · New financial obligation
- Oct 15, 20268-KCurrent reportMaterial agreement · New financial obligation · Unregistered share sale
- Oct 9, 20268-KCurrent reportAuditor change
- Oct 5, 20268-KCurrent reportMaterial agreement · New financial obligation
- Sep 21, 20268-KCurrent reportShareholder vote
- Sep 16, 20268-KCurrent reportMaterial agreement · New financial obligation
- Sep 15, 20268-KCurrent reportOther events
- Sep 1, 20268-KCurrent reportMaterial agreement · New financial obligation
- Aug 31, 20268-KCurrent reportListing notice
- Aug 28, 2026DEF 14AProxy statement
- Aug 21, 20268-KCurrent reportMaterial agreement · New financial obligation · Unregistered share sale
- Aug 20, 20268-KCurrent reportResults of operations
Official filings of Profusa, Inc. with the US Securities and Exchange Commission.
Annual results
- Revenue
- —
- Operating income
- $-28 M
- Net income
- $-36 M
For year ending December-2025 · source: SEC filing
Balance sheet
- Total assets
- $4 M
- Total liabilities
- $30 M
- Total equity
- $-27 M
As of December-2025
Top 6 institutional investors in Profusa, Inc.#
| # | Institution | Shares held | Change (shares) | % held | Value | Filed |
|---|---|---|---|---|---|---|
| 1 | HRT Financial LP | 18,033 | New | 2.98% | $0 M | Nov 13, 2026 |
| 2 | Tower Research Capital LLC (TRC) | 2,615 | New | 0.43% | $0 M | Nov 16, 2026 |
| 3 | SBI Securities Co., Ltd. | 2,287 | New | 0.38% | $0 M | Oct 22, 2026 |
| 4 | Vanguard Capital Management LLC | 39 | New | 0.01% | $0 M | Nov 13, 2026 |
| 5 | UBS Group AG | 13 | New | 0.00% | $0 M | Nov 10, 2026 |
| 6 | Mint Tower Capital Management B.V. | 1 | New | 0.00% | $0 M | Nov 9, 2026 |
Insider trading at Profusa, Inc.#
Shares bought and sold by directors, officers and 10% owners, from their SEC Form 4 filings.
| Traded | Insider | Trade | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|
| filed | Jack E. StoverChief Executive Officer | Other | +32,018 | — | — | 32,091 | Form 4 |
| filed | Fred S. KnechtelChief Financial Officer | Other | +54,323 | — | — | 54,470 | Form 4 |
| filed | Jack E. StoverChief Executive Officer | Otherindirect | -301,991 | — | — | 0 | Form 4 |
| filed | Fred S. KnechtelChief Financial Officer | Otherindirect | -301,991 | — | — | 0 | Form 4 |
| filed | HRT Financial LP10% owner | Sell | -18,395 | $5.940 | $109 K | 0 | Form 4 |
| filed | HRT Financial LP10% owner | Sell | -3,163 | $0.900 | $3 K | 71,035 | Form 4 |
| filed | HRT Financial LP10% owner | Sell | -42,411 | $0.890 | $38 K | 74,198 | Form 4 |
| filed | Fred S. KnechtelChief Financial Officer | Conversionindirect | +301,991 | $4.280 | — | 301,991 | Form 4 |
Source: SEC Forms 4 and 5. Awards, option exercises and shares withheld for tax are listed but not counted in the totals
Markets and events: Profusa, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
| Buybacks, quarter | Fiscal | Spent |
|---|---|---|
| Q2 2025 | Q2 2025 | $0M |
| Q1 2025 | Q1 2025 | $6.5M |
| Q4 2024 | Q4 2024 | $0.6M |
| Q3 2024 | Q3 2024 | $0M |
| Q2 2024 | Q2 2024 | $0M |
| Q1 2024 | Q1 2024 | $2.7M |
| Q4 2023 | Q4 2023 | $0M |
| Q3 2023 | Q3 2024 | $0M |
| Q2 2023 | Q2 2024 | $0M |
| Q1 2023 | Q1 2024 | $184.8M |
Trading halts
- 2026-08-28 16:24 UTC, code LUDP, resumed 16:29 UTC
- 2026-08-24 13:48 UTC, code LUDP, resumed 13:53 UTC
- 2026-08-24 13:36 UTC, code LUDP, resumed 13:46 UTC
- 2026-08-20 14:06 UTC, code LUDP, resumed 14:11 UTC
- 2026-08-20 13:33 UTC, code LUDP, resumed 13:38 UTC
Fails to deliver
- : 15,116 shares at $0.77
- : 16,631 shares at $0.78
- : 254,783 shares at $1.02
- : 1,989 shares at $0.89
- : 774 shares at $0.93
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
Profusa, Inc. scorecard#
Passes 0 of the 8 checks that could be worked out. Fiscal year 2025; market cap of Oct 29, 2026.
Valuation0 of 3
- ✗P/E below its peers' medianNo P/EThe company made a loss over the last twelve months.
- ✗Price to book below its peers' medianNo price to bookShareholders' equity is negative.
- –Price to sales below its peers' medianNo Price to sales on file.
- –Free cash flow yield above 5%No free cash flow yield on file.
- ✗Earnings yield above the 10-year Treasury yieldLossA loss earns nothing against the 10-year Treasury's 5.15% (2026-11-13).
- –The price assumes slower growth than the last three years'Free cash flow of the last three years is missing or below zero on average.
Growth0 of 1
- –Revenue grew in the newest yearRevenue of the year before is not on file.
- –Revenue up more than 5% a year over three yearsRevenue of three years earlier is not on file.
- –Faster growth over three years than its peers' medianRevenue of three years earlier is not on file.
- ✗Earnings per share grew in the newest year-107.01 vs -357.14Diluted EPS -107.01 in fiscal 2025 against -357.14 the year before (report's currency).
- –Net income higher than five years earlierNet income of five years earlier is not on file.
- –Revenue rose in at least four of the last five yearsFive years of revenue changes are not on file.
Profitability0 of 1
- ✗Profitable in the newest year-$36 MNet income -$36 M in fiscal 2025.
- –Profitable in each of the last five yearsFive years of net income are not on file.
- –Operating margin above its peers' medianNo operating margin on file.
- –Return on equity above 15%No return on equity (equity missing or negative).
- –Return on invested capital above 10%No return on invested capital on file.
- –Operating margin wider than three years earlierOperating margins of three years earlier are not on file.
Financial health0 of 3
- ✗Short-term assets cover short-term liabilities0.2×Current ratio 0.17 at the end of fiscal 2025.
- –Debt below equityDebt or equity is not on file (or equity is negative).
- –Net debt below three years of EBITDANet debt to EBITDA is not on file.
- ✗Operating income covers interest five times-11.0×Operating income -11.0 times interest in fiscal 2025.
- ✗Cash from operations positive in each of the last three years0 of 3Positive in 0 of the three years to fiscal 2025.
- –Altman Z-score outside the distress zoneThe Z-score's figures are not all on file.
Shareholder returnsnot known
- –Pays a dividendDividends are not on file.
- –Dividend per share raised five years in a rowSix years of dividends per share are not on file.
- –Dividends under 75% of net incomePays no dividend (or dividends are not on file).
- –Share count up no more than 2% in a yearShare counts of two years are not on file.
- –Dividends and buybacks above 3% of the market valueDividends and buybacks are not on file.
- –Free cash flow covers dividends and buybacksPaid out nothing in the newest year.
Worked out from the statements as filed (sec), the 10-year Treasury yield of Nov 13, 2026 and the market cap. A check that cannot be worked out counts neither way. A reading aid, not advice. How the checks work
Profusa, Inc.: financial statements#
Income statement, balance sheet and cash-flow statement as reported, newest period first.
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | FY 2025to Dec 31, 2025 | FY 2024to Dec 31, 2024 | FY 2023to Dec 31, 2023 | FY 2022to Dec 31, 2022 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | — | 0.1—100% | — | — | |
| Research and development | 2.8+74.4%— | 1.6—1608% | — | — | |
| General and administrative | 25+732%— | 3.0—2992% | — | — | |
| Operating expenses | 28+502%— | 4.6—4600% | — | — | |
| Operating income | −28—— | −4.5r−1.4—−4500% | −1.5—— | −1.3—— | |
| Interest and finance income | — | 0.4−81.1%425% | 2.2−12.8%— | 2.6—— | |
| Interest expense and finance costs | 2.5−43.0%— | 4.4—4424% | — | — | |
| Other non-operating income (expense) | −8.1—— | −4.7r−7.3−251%−4730% | 3.1−65.0%— | 8.9—— | |
| Income before tax | — | −8.6−633%−8631% | 1.6−78.9%— | 7.7—— | |
| Income tax | — | 0.1−82.4%80.5% | 0.5−8.5%— | 0.5—— | |
| Net income attributable to shareholders | −36—— | −9.2r−8.7−894%−9230% | 1.2−83.8%— | 7.2—— | |
| Earnings per share, basic | -107.01—— | -357.14r-1.47−297717%— | 0.12−60.0%— | 0.30—— | |
| Earnings per share, diluted | -107.01—— | -357.14r-1.47−297717%— | 0.12−60.0%— | 0.30—— | |
| Shares, weighted average (basic) | 0.3+1195%— | 0.0r5.2−99.5%— | 5.20.0%— | 5.2—— | |
| Shares, weighted average (diluted) | 0.3+1195%— | 0.0r5.2−99.5%— | 5.20.0%— | 5.2—— | |
| Balance sheet | |||||
| Cash and cash equivalents | 1.8+831%47.1% | 0.2r0.0+4127%6.2% | 0.0−97.7%0.0% | 0.2—0.1% | |
| Other current assets | 0.5+684%14.3% | 0.1r0.0+922%2.2% | 0.0−97.9%0.1% | 0.3—0.2% | |
| Current assets | 3.8+1348%99.7% | 0.3r0.1−83.5%8.5% | 1.6+208%14.5% | 0.5—0.3% | |
| Property, plant and equipment | 0.0—0.2% | — | — | — | |
| Total assets | 3.8+22.8%100% | 3.1r8.4−71.8%100% | 11−94.4%100% | 195—100% | |
| Accounts payable | 7.3+48.3%195% | 5.0—161% | — | — | |
| Current liabilities | 22−61.0%590% | 57r12+1061%1859% | 4.9+426%45.2% | 0.9—0.5% | |
| Total liabilities | 30−46.7%806% | 57r13+1022%1859% | 5.1+178%46.8% | 1.8—0.9% | |
| Retained earnings | −161—−4259% | −125r−13—−4066% | −3.5—−31.8% | −0.6—−0.3% | |
| Shareholders' equity | −27—−706% | −119r−13—−3879% | −110r−3.5—−1011% | −0.6—−0.3% | |
| Total liabilities and equity | 3.8+22.8%100% | 3.1r8.4−71.8%100% | 11−94.4%100% | 195—100% | |
| Shares outstanding | 0.0r1.2−52.3%— | 0.0r5.2−99.5%— | 5.20.0%— | 5.2—— | |
| Cash-flow statement | |||||
| Share-based compensation | 0.9+4143%— | 0.0—21.0% | — | — | |
| Cash from operating activities | −16—— | −2.1r−1.3—−2066% | −2.1—— | −0.6—— | |
| Capital expenditure | −0.0—— | — | — | — | |
| Cash from investing activities | −2.0−168%— | 3.0−98.4%2968% | 186+554808%— | 0.0—— | |
| Debt repaid | −1.9—— | — | — | — | |
| Shares issued | — | — | — | 7.7r−7.7—— | |
| Shares bought back | — | −3.2—−3249% | −185—— | — | |
| Cash from financing activities | 20+838%— | 2.1r−1.7—2115% | −184—— | — | |
| Report | 10-K | 10-K | 10-K | 10-K | |
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Amounts in USD millions; per-share figures in USD; share counts in millions. Hover a figure for its filing and XBRL tag. Growth compares with the same quarter a year before; shares are of revenue (income and cash flow) or of total assets (balance sheet).
| Period | Trend | Last 12 months4 quarters to Sep 30, 2026 | Q3 FY2026to Sep 30, 2026 | Q2 FY2026to Jun 30, 2026 | Q1 FY2026to Mar 31, 2026 | Q4 FY2025to Dec 31, 2025 | Q3 FY2025to Sep 30, 2025 | Q2 FY2025to Jun 30, 2025 | Q1 FY2025to Mar 31, 2025 | Q2 FY2024to Jun 30, 2024 | Q1 FY2024to Mar 31, 2024 | Q4 FY2023to Dec 31, 2023 | Q3 FY2023to Sep 30, 2023 | Q2 FY2023to Jun 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||||||
| Research and development | 3.4—— | 0.2−69.3%— | 0.8+109%— | 1.1+164%— | 1.3*—— | 0.7—— | 0.4—— | 0.4—— | — | — | — | — | — | |
| General and administrative | 12—— | 4.6−77.9%— | 1.7+182%— | 2.9+189%— | 2.3*—— | 21—— | 0.6—— | 1.0—— | — | — | — | — | — | |
| Operating expenses | 15—— | 4.9−77.6%— | 2.5+154%— | 4.0+181%— | 3.6*—— | 22—— | 1.0—— | 1.4r0.0—— | — | — | — | — | — | |
| Operating income | −15—— | −4.9—— | −2.5—— | −4.0—— | −3.6*—— | −22—— | −1.0r−1.0—— | −1.4r−0.6—— | −0.3—— | −0.5—— | −0.5*—— | −0.3—— | −0.3—— | |
| Interest and finance income | — | — | — | — | — | — | 0.0−86.0%— | 0.1−31.5%— | 0.1−11.4%— | 0.1—— | 0.1*—— | 0.1—— | 0.1—— | |
| Interest expense and finance costs | 0.1—— | 0.0−87.0%— | 0.0−98.2%— | 0.0−98.4%— | 0.0*—— | 0.2—— | 1.2—— | 1.1—— | — | — | — | — | — | |
| Other non-operating income (expense) | −6.9—— | −0.1—— | −6.2—— | 0.6—— | −1.1r−5.0*—— | −4.4r−0.5—— | −1.3r−7.2—— | −1.3r−0.5—— | −0.1−110%— | −0.3—— | 0.7*—— | −0.1—— | 1.2—— | |
| Income before tax | — | — | — | — | — | — | −8.2—— | −1.1—— | −0.4−143%— | −0.8—— | 0.3*—— | −0.3—— | 0.9—— | |
| Income tax | — | — | — | — | — | — | 0.0−89.6%— | 0.0−9.8%— | 0.0+5.1%— | 0.0—— | 0.0*—— | 0.0—— | 0.0—— | |
| Net income attributable to shareholders | −22—— | −5.0—— | −8.8—— | −3.5—— | −4.7r−8.6*—— | −26r−22—— | −2.3r−8.2—— | −2.7r−1.1—— | −2.4r−0.4−383%— | −2.1r−0.8—— | 0.2*—— | −0.4—— | 0.9—— | |
| Earnings per share, basic | — | -6.23—— | -151.80—— | -2.05—— | — | -6,167.85r-0.70—— | -9,100.78r-1.53—— | -105.09r-0.19—— | -0.07−150%— | -0.14—— | — | -0.06—— | 0.14—— | |
| Earnings per share, diluted | — | -6.23—— | -151.80—— | -2.05—— | — | -6,167.85r-0.70—— | -9,100.78r-1.53—— | -105.09r-0.19—— | -0.07−150%— | -0.14—— | — | -0.06r0.14—— | 0.14—— | |
| Shares, weighted average (basic) | 0.8—— | 0.8+18692%— | 0.1+22255%— | 1.7+6432%— | — | 0.0r32—— | 0.0r5.2−100.0%— | 0.0r5.2−99.5%— | 5.20.0%— | 5.2—— | — | 5.2—— | 5.2—— | |
| Shares, weighted average (diluted) | 0.8—— | 0.8+18692%— | 0.1+22255%— | 1.7+6432%— | — | 0.0r32—— | 0.0r5.2−100.0%— | 0.0r5.2−99.5%— | 5.20.0%— | 5.2—— | — | 5.2—— | 5.2—— | |
| Balance sheet | ||||||||||||||
| Cash and cash equivalents | 8.4—29.1% | 8.4+179%29.1% | 12+31182%1171% | 0.4+1874%43.5% | 1.8—47.1% | 3.0—70.8% | 0.0r0.0+500%2.0% | 0.0r0.0+258%1.0% | 0.0+11.8%0.1% | 0.0—0.1% | 0.0—0.0% | 0.0—0.2% | 0.0—0.1% | |
| Other current assets | 0.1—0.2% | 0.1−74.3%0.2% | 0.1—11.7% | 0.3+1922%33.3% | 0.5—14.3% | 0.2—5.0% | — | 0.0−76.6%0.7% | 0.0−82.4%0.5% | 0.1—0.7% | 0.0—0.1% | 0.1—1.3% | 0.2—2.1% | |
| Current assets | 0.4—1.4% | 0.4−90.6%1.4% | 0.8+22.3%80.7% | 0.7+948%76.8% | 3.8—99.7% | 4.2—98.7% | 0.7+506%35.1% | 0.1−4.4%3.2% | 0.1−51.8%1.3% | 0.1—0.8% | 1.6—14.5% | 0.2—1.4% | 0.2—2.2% | |
| Property, plant and equipment | 0.1—0.3% | 0.1—0.3% | 0.1—8.1% | 0.0—1.5% | 0.0—0.2% | — | — | — | — | — | — | — | — | |
| Right-of-use (leased) assets | — | — | 0.1—9.6% | 0.1—11.6% | — | — | — | — | — | — | — | — | — | |
| Total assets | 29—100% | 29+580%100% | 1.0−46.9%100% | 0.9−56.5%100% | 3.8—100% | 4.3—100% | 2.0−77.2%100% | 2.0−76.7%100% | 8.6−21.2%100% | 8.5—100% | 11—100% | 11—100% | 11—100% | |
| Accounts payable | 10—34.8% | 10+44.2%34.8% | 7.9—754% | 8.3—964% | 7.3—195% | 7.0—164% | — | — | — | — | — | — | — | |
| Customer deposits | — | — | — | — | — | — | 0.0—1.5% | 0.0—0.7% | — | — | — | — | — | |
| Current liabilities | 21—73.0% | 21−10.4%73.0% | 28+74.1%2703% | 29+119%3367% | 22—590% | 24—554% | 16+289%825% | 13+234%668% | 4.2+40.1%48.4% | 4.0—46.6% | 4.9—45.2% | 3.0—27.8% | 3.0—27.2% | |
| Total liabilities | 21—73.0% | 21−44.8%73.0% | 28+21.7%2703% | 29+103%3371% | 30—806% | 38—899% | 23+353%1179% | 14+209%721% | 5.1+50.8%59.5% | 4.6—54.4% | 5.1—46.8% | 3.7—33.9% | 3.4—31.1% | |
| Retained earnings | −178—−616% | −178−4663%−616% | −173—−16602% | −164—−19053% | −161—−4259% | 3.9r−152—91.8% | −23—−1147% | −14—−721% | −5.1—−59.1% | −4.5—−52.9% | −3.5—−31.8% | −3.5—−32.2% | −2.9—−26.4% | |
| Shareholders' equity | 7.8—27.0% | 7.8—27.0% | −27—−2603% | −28—−3271% | −27—−706% | −34r−34—−798% | −124r−23—−6328% | −122r−14—−6146% | −114r−5.1—−1333% | −112r−4.5—−1318% | −110r−3.5—−1011% | −3.5—−32.2% | −2.9—−26.4% | |
| Total liabilities and equity | 29—100% | 29+580%100% | 1.0−46.9%100% | 0.9−56.5%100% | 3.8—100% | 4.3—100% | 2.0−77.2%100% | 2.0−76.7%100% | 8.6−21.2%100% | 8.5—100% | 11—100% | 11—100% | 11—100% | |
| Shares outstanding | 2.5—— | 2.5−94.0%— | 0.1−97.5%— | 2.4−54.2%— | 0.0r1.2—— | 42—— | 5.20.0%— | 5.20.0%— | 5.20.0%— | 5.2—— | 5.2—— | 5.2—— | 5.2—— | |
| Cash-flow statement | ||||||||||||||
| Share-based compensation | 0.7—— | 0.1−79.6%— | 0.2+129%— | 0.2+3640%— | 0.2*—— | 0.6—— | 0.1—— | 0.0—— | — | — | — | — | — | |
| Cash from operating activities | −12—— | −1.7*—— | −2.6*—— | −2.6—— | −5.1*—— | −10.0r−11*—— | −0.6r−0.1*—— | −0.5r−0.4—— | −0.4*—— | −0.3—— | −0.3*—— | −0.5*—— | −0.3*—— | |
| Capital expenditure | — | −0.0*—— | −0.1*—— | −0.0—— | — | — | — | — | — | — | — | — | — | |
| Cash from investing activities | 0.1—— | −0.0*—— | −0.1*—— | 1.1−82.4%— | −1.0*—— | −7.5*—— | −0.0*−100%— | 6.5+154%— | 0.1*—— | 2.6—— | −0.1*—— | 0.1*—— | −0.1*—— | |
| Debt issued | — | 1.3*—— | — | — | — | — | — | — | — | — | — | — | — | |
| Debt repaid | — | — | — | — | −1.3*—— | — | — | — | — | — | — | — | — | |
| Shares issued | — | — | — | — | — | — | — | — | — | — | — | 0*—— | 0*—— | |
| Shares bought back | — | — | — | — | — | — | 0*—— | −6.5—— | 0*—— | −2.7—— | 0*—— | 0*—— | 0*—— | |
| Cash from financing activities | 9.3—— | 1.3*−90.7%— | 3.0*+401%— | 0.0−92.3%— | 4.9*—— | 14r21*—— | 0.6r0.1*+84.1%— | 0.4r−6.1—— | 0.3*−10.5%— | −2.3—— | 0.4*—— | 0.3*—— | 0.4*—— | |
| Report | Worked out | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | |
* Worked out from reported figures: a quarter the company states only within a year-to-date figure (cash flows are reported that way), or the fourth quarter as the fiscal year minus the first nine months.
r Changed after it was first reported (a restatement, a reclassification or a later report's rounding); hover for the first value and filing, or show every figure as first reported: what investors could read at the time, without look-ahead. Restatements across companies
Build a DCF model from these statements: revenue, margins, tax, depreciation, capital spending, working capital, debt, cash and shares filled in from the annual reports, every assumption yours.
Source: SEC EDGAR filings (XBRL) · as of Sep 30, 2026. A fiscal year is listed under the calendar year it mostly falls in; quarters are numbered within the company's fiscal year. Balance-sheet figures are those at the end of each period. Payments in the cash-flow statement are negative
Events at Profusa, Inc.#
What the company reported to the SEC within four business days (Form 8-K), newest first.
Warning signs in the last three years
Delisting notice 2 · Auditor changed 1 · Taken over and delisted 1 · Acquisition or sale completed 1 · Directors and officers 1 · Material agreement 14 · Agreement ended 1 · New debt 9 · Unregistered share sale 5 · Shareholder rights changed 4 · Bylaws or fiscal year changed 4 · Shareholder vote 2 · Results announced 1
| Filed | What happened | Filing |
|---|---|---|
| Material agreementNew debt | 8-K | |
| Material agreementNew debtUnregistered share sale | 8-K | |
| Auditor changed | 8-K | |
| Material agreementNew debt | 8-K | |
| Shareholder vote | 8-K | |
| Material agreementNew debt | 8-K | |
| Material agreementNew debt | 8-K | |
| Delisting notice | 8-K | |
| Material agreementNew debtUnregistered share sale | 8-K | |
| Results announced | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Material agreementUnregistered share saleBylaws or fiscal year changed | 8-K | |
| Directors and officers | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K | |
| Shareholder vote | 8-K | |
| Material agreement | 8-K | |
| Delisting noticeMaterial agreementNew debtShareholder rights changed | 8-K | |
| Material agreementUnregistered share sale | 8-K | |
| Material agreementNew debt | 8-K | |
| Material agreementNew debtUnregistered share sale | 8-K | |
| Material agreement | 8-K | |
| Taken over and delistedAcquisition or sale completedAgreement ended | 8-K | |
| Material agreement | 8-K | |
| Shareholder rights changedBylaws or fiscal year changed | 8-K |
Source: SEC EDGAR, Form 8-K item numbers · as of Nov 6, 2026
H-1B hiring at Profusa, Inc.#
1 labor condition applications certified in fiscal 2024 for 1 positions, at a median wage of $102 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Research AnalystMarket Research Analysts and Marketing Specialists | 1 | $102 K |
Where: Emeryville, CA 1
| Fiscal year | Certified | Positions | Median wage | Filed |
|---|---|---|---|---|
| FY2024 | 1 | 1 | $102 K | 1 |
| FY2021 | 1 | 1 | $71 K | 1 |
| FY2020 | 1 | 1 | $114 K | 1 |
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Profusa, Inc.
Questions, comparisons and similar companies#
Questions people ask
Sources and freshness
- Market cap:
- Oct 29, 2026
- Annual results:
- For year ending December-2025
- Balance sheet:
- As of December-2025
- Profile updated:
- Nov 20, 2026
Figures from Market data, SEC filing, value.today research, SEC annual report; financial statements from SEC filings.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Profusa, Inc.? Verify and update this profile — free
Show Profusa, Inc.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.